Skip to main content
Log in

Ethics Review of Biomedical Research in Uzbekistan: Policy and Program Gaps

  • Perspective
  • Published:
Asian Bioethics Review Aims and scope Submit manuscript

Abstract

We describe the national health research ethics review system of Uzbekistan and identify policy and program gaps that impede the protection of human research subjects. We find that the National Ethic Committee (NEC), functioning at the national level, is solely responsible for conducting research ethics review. There is little evidence that regional ethics committees work as intended, and there is no research ethics review at medical institutes and research centers even though they conduct CDTs (clinical drug trials). There is no national policy for the ethical review of non-clinical trials. We recommend the establishment of institutional review boards (IRBs) at medical institutes and research centers while at the same time building capacity at the national level to oversee and support the research ethics review system of the entire country.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data Availability

Not applicable.

Notes

  1. Guideline for Good Clinical Practice of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH).

  2. The Ethical Code of Uzbekistan Physician-Investigator. Sets out basic principles of ethical review of biomedical research involving human subjects.

  3. Guidelines on Conducting Clinical Trials and Determining Clinical Sites.” The Guidelines are based on WHO Guidelines for Good Clinical Practice and reflect the following aspects: informing patients about CT; obtaining written informed consent from patients; independent ethical review; operational standard procedures.

Abbreviations

CDT :

clinical drug trial

IRB :

Institutional Review Board

NEC :

National Ethics Committee

REC :

Research Ethics Committees

SOP :

standard operational procedures

TIPME :

Tashkent Institute of Postgraduate Medical Education

WHO :

World Health Organization

References

Download references

Author information

Authors and Affiliations

Authors

Contributions

Both authors contributed to the study conception and design. Data collection and analysis were performed by Dilfuza Aniyozova. Both authors commented on previous versions of the manuscript. Both authors read and approved the final manuscript.

Corresponding author

Correspondence to Dilfuza Aniyozova.

Ethics declarations

Ethics Approval

This is a qualitative research/policy analysis. The study did not require an ethical approval.

Competing Interests

The authors declare no competing interests.

Consent

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aniyozova, D., Strosberg, M.A. Ethics Review of Biomedical Research in Uzbekistan: Policy and Program Gaps. ABR (2024). https://doi.org/10.1007/s41649-023-00273-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s41649-023-00273-2

Keywords

Navigation